N
NXTC icon

Nuveen’s NextCure NXTC Stock Holding History

Nuveen’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,545
Closed -$666K – 3488
2021
Q1 		$666K Buy
5,545
+134
+2% +$19.4K ﹤0.01% 3022
2020
Q4 		$708K Buy
5,411
+90
+2% +$11.6K ﹤0.01% 2922
2020
Q3 		$562K Sell
5,321
-775
-13% -$95.3K ﹤0.01% 2914
2020
Q2 		$1.57M Sell
6,096
-726
-11% -$276K ﹤0.01% 2437
2020
Q1 		$3.04M Sell
6,822
-76
-1% -$40.6K ﹤0.01% 1980
2019
Q4 		$4.66M Buy
6,898
+3,210
+87% +$1.61M ﹤0.01% 2035
2019
Q3 		$1.36M Buy
3,688
+2,660
+259% +$865K ﹤0.01% 2562
2019
Q2 		$185K Buy
+1,028
New +$214K ﹤0.01% 3185

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen's NXTC Position: Q2 2021 in Review

Nuveen sold out of NextCure (NXTC) in Q2 2021, closing a stake of 5,545 shares — an estimated $666K sold.

Nuveen first reported a position in NXTC in Q2 2019 and held it in 8 quarters. The position peaked at $4.66M in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Nuveen reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 5,545 NextCure shares in Q2 2021, an estimated $666K.
  • Nuveen first reported a position in NextCure in Q2 2019 and held it in 8 quarters.
  • Nuveen's NextCure position peaked at $4.66M in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.